• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Pharma industry news

GS-4774

Top-line results announced for Phase 2 study of GS-4774 in patients with chronic hepatitis B

28 May 2015

Top line results have been announced from the GS-4774 Phase 2 study in patients with HBV on long term viral suppression with an oral antiviral treatment...

antiretroviral

Starting antiretroviral treatment early improves outcomes for HIV-infected individuals

28 May 2015

A trial has found that HIV-infected individuals have a lower risk of developing AIDS or other serious illnesses if given antiretroviral drugs sooner...

boehringer-ingelheim-Stiolto-Respimat

FDA approves Stiolto Respimat Inhalation Spray as once-daily maintenance treatment of COPD

28 May 2015

The US Food and Drug Administration has approved Boehringer Ingelheim’s once-daily Stiolto Respimat (tiotropium bromide and olodaterol) Inhalation Spray...

european-business-awards

Pharmaceutical sector celebrates as three companies named winners in European Business Awards

28 May 2015

The pharmaceuticals sector is celebrating a triple win following the 2014/15 European Business Awards exclusive awards ceremony in London...

stelara

STELARA receives CHMP positive opinion for treatment of adolescents with moderate to severe psoriasis

27 May 2015

The CHMP has recommended approval of STELARA for the treatment of moderate to severe plaque psoriasis in adolescent patients aged 12 and older...

saxenda-novo-nordisk

Treatment with Saxenda for three years reduced the risk of developing type 2 diabetes

27 May 2015

The SCALE Obesity and Prediabetes trial met its primary endpoint, demonstrating that ongoing treatment with Saxenda delayed the onset of type 2 diabetes...

melanoma-talimogene-laherparepvec

Pivotal study results show talimogene laherparepvec improved durable response rates in patients with metastatic melanoma

27 May 2015

Primary results from a Phase 3 study demonstrates a significantly higher DRR in patients with metastatic melanoma receiving the talimogene laherparepvec...

kidney-tolvaptan

Otsuka’s JINARC (tolvaptan) becomes first-ever treatment approved in Europe for adults living with ADPKD

27 May 2015

The EC has granted marketing authorisation for tolvaptan for the treatment of ADPKD in adults who have chronic kidney disease (CKD)...

advanced-wound

Global advanced wound dressings market value to reach $3.51 billion by 2021, says GlobalData

27 May 2015

The global market value for advanced wound dressings will increase to reach $3.51 billion by 202, according to research and consulting firm GlobalData...

aloxi-needle

European Commission approves ALOXI injection to prevent nausea and vomiting due to chemotherapy in children as young as one month

27 May 2015

Helsinn Group has announced that the European Commission has approved ALOXI injection for the prevention of acute CINV in children aged one to six months...

fycompa-epilepsy

Eisai receives positive CHMP opinion on indication expansion for antiepileptic agent Fycompa as adjunctive treatment of PGTC seizures

27 May 2015

Eisai has received a positive opinion from the EMA’s CHMP for the use of Fycompa for the adjunctive treatment of PGTC seizures...

aeterna-zentaris-macrilen

Aeterna Zentaris’ confirmatory Phase 3 study for Macrilen in AGHD meets EMA’s study-design expectations

27 May 2015

Aeterna Zentaris has received advice from the EMA regarding the development plan for the new confirmatory Phase 3 clinical study of Macrilen in AGHD...